Gala Renee D (CIK 0001607737)

Latest company ownership

Shares held
157,657
Last filed at
Nov 21, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4
Shares held
107,869
Last filed at
Aug 11, 2025
Confidence Score
51.1
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
10,000
Last filed at
Mar 7, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Dec 9, 2025 Jazz Pharmaceuticals plc CEO Sell 51.3 -80 -0.07% ✗ $13.4K
Mar 5, 2025 Mar 7, 2025 Jazz Pharmaceuticals plc COO Sell 20.0 -5,704 -6.03% ✗ $792.6K
Jan 17, 2025 Jan 22, 2025 Jazz Pharmaceuticals plc COO Sell 92.5 +4,441 8.00% ✗ $404.6K
Dec 5, 2024 Dec 9, 2024 Jazz Pharmaceuticals plc COO Sell 52.5 -80 -0.14% ✗ $9.9K
Apr 5, 2024 Apr 9, 2024 Jazz Pharmaceuticals plc COO Sell 22.5 -1,736 -3.04% ✗ $200K
Mar 5, 2024 Mar 7, 2024 Jazz Pharmaceuticals plc COO Sell 20.0 -3,622 -5.97% ✗ $425.7K
Jan 17, 2024 Jan 19, 2024 Jazz Pharmaceuticals plc COO Sell 97.5 +3,875 10.49% ✗ $381.7K
May 18, 2023 May 19, 2023 Jazz Pharmaceuticals plc CFO Sell 20.0 -6,000 -14.29% ✗ $790.5K
Apr 5, 2023 Apr 7, 2023 Jazz Pharmaceuticals plc CFO Sell 20.0 -1,807 -4.13% ✗ $263.4K
Mar 3, 2023 Mar 7, 2023 Jazz Pharmaceuticals plc CFO Sell 95.0 +11,227 34.48% ✗ $222.3K
Dec 21, 2022 Dec 22, 2022 Jazz Pharmaceuticals plc CFO Sell 30.0 -2,635 -7.49% ✓ $421.6K
Apr 5, 2022 Apr 7, 2022 Jazz Pharmaceuticals plc CFO Sell 20.0 -1,633 -4.46% ✗ $266K
Mar 3, 2022 Mar 9, 2022 Jazz Pharmaceuticals plc CFO Sell 95.0 +11,010 42.98% ✗ $110.9K
Apr 5, 2021 Apr 7, 2021 Jazz Pharmaceuticals plc CFO Sell 22.5 -1,515 -5.64% ✗ $249.5K
Nov 20, 2018 Nov 21, 2018 Theravance Biopharma, Inc. CFO Sell 22.5 -6,697 -4.07% ✗ $166K
Aug 20, 2018 Aug 22, 2018 Theravance Biopharma, Inc. CFO Sell 22.5 -6,695 -3.91% ✗ $180.4K
Aug 14, 2018 Aug 16, 2018 Theravance Biopharma, Inc. CFO Sell 17.5 -43,743 -20.37% ✗ $1.2M
May 18, 2018 May 22, 2018 Theravance Biopharma, Inc. CFO Sell 20.0 -31,230 -12.69% ✗ $759K
Mar 6, 2018 Mar 7, 2018 CORCEPT THERAPEUTICS INC Director Buy 95.0 +10,000 100.00% ✗ $155.1K
Feb 20, 2018 Feb 22, 2018 Theravance Biopharma, Inc. CFO Sell 22.5 -5,387 -2.48% ✗ $156.7K
Nov 20, 2017 Nov 22, 2017 Theravance Biopharma, Inc. CFO Sell 22.5 -6,753 -3.15% ✗ $193K
Aug 20, 2017 Aug 22, 2017 Theravance Biopharma, Inc. CFO Sell 22.5 -6,752 -3.05% ✗ $185K
May 20, 2017 May 23, 2017 Theravance Biopharma, Inc. CFO Sell 22.5 -6,753 -2.96% ✗ $248.7K
Feb 20, 2017 Feb 22, 2017 Theravance Biopharma, Inc. CFO Sell 20.0 -10,211 -4.32% ✗ $344.9K
Nov 20, 2016 Nov 22, 2016 Theravance Biopharma, Inc. CFO Sell 22.5 -4,628 -1.99% ✗ $147.9K
Aug 20, 2016 Aug 23, 2016 Theravance Biopharma, Inc. CFO Sell 22.5 -4,306 -1.82% ✗ $120.1K
May 20, 2016 May 24, 2016 Theravance Biopharma, Inc. CFO Sell 22.5 -3,333 -1.39% ✗ $68.5K
Feb 20, 2016 Feb 23, 2016 Theravance Biopharma, Inc. CFO Sell 22.5 -13,052 -8.10% ✗ $204.3K
Aug 13, 2015 Aug 17, 2015 Theravance Biopharma, Inc. CFO Buy 87.5 +10,000 3.27% ✗ $121.8K
Aug 20, 2014 Aug 22, 2014 Theravance Biopharma, Inc. SVP-Finance Sell 27.5 -158 -1.09% ✗ $4.3K